Boothbay Fund Management, LLC Eledon Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$2.45 - $3.88 $30,821 - $48,810
-12,580 Reduced 36.33%
22,050 $61,000
Q3 2021

Nov 15, 2021
SELL
$5.94 - $8.46 $32,206 - $45,870
-5,422 Reduced 13.54%
34,630 $214,000
Q2 2021

Aug 16, 2021
BUY
$7.62 - $11.75 $86,563 - $133,480
11,360 Added 39.59%
40,052 $317,000
Q1 2021

May 17, 2021
BUY
$9.85 - $19.22 $282,616 - $551,460
28,692 New
28,692 $307,000

Others Institutions Holding ELDN

# of Institutions
34
Shares Held
18.4M
Call Options Held
0
Put Options Held
0
View Full List

About Eledon Pharmaceuticals, Inc.

ELDN Quotes by TradingView
  • Ticker ELDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,756,800
  • Market Cap $60M
  • Description
  • Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...
More about ELDN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email